Document Detail

Concomitant diseases in a cohort of patients with idiopathic myositis during long-term follow-up.
MedLine Citation:
PMID:  19387765     Owner:  NLM     Status:  MEDLINE    
This study aims to report the concomitant diseases observed and damage outcome in a cohort of patients with adult idiopathic inflammatory myositis (IIM) during long-term follow-up. All patients with IIM were identified from a single centre (follow-up between 1979 and 2006) and fulfilled at least three of the four Bohan and Peter criteria. Patients with inclusion body myositis, juvenile-onset myositis and overt overlap syndromes were excluded. Medical notes were retrospectively reviewed. Concomitant diseases identified were divided into 12 different organ systems (bone, cardiac, respiratory, gastrointestinal, renal, central nervous, malignancy, infection, endocrine, eyes, dermatological and haematological). Patient damage index was calculated using the Myositis Damage Index tool. Fifty-five patients (31 polymyositis, 24 dermatomyositis) were identified. The most prevalent organ system involved was lung with 40 events per 1,000 patient years follow-up. There was significant steroid-related complications with 17/18 patients with bone involvement having osteopenia/osteoporosis. Sjogren's syndrome (n = 3) was the most frequent concomitant auto-immune disease observed. Patients with a higher number of organ systems involved had a significantly higher damage index (r = 0.48, p = 0.001). White patients showed a significant trend to develop more than three other organ system involvement (p < 0.0001) and myositis-related lung disease (p < 0.0001) compared to other races. There is significant steroid-related morbidity in adult IIM patients under long-term follow-up. The prevalence of another concomitant auto-immune disease unlike patients with lupus or Sjogren's syndrome is low.
K P Ng; F Ramos; S M Sultan; D A Isenberg
Related Documents :
406335 - Leukocyte alkaline phosphatase levels in multiple myeloma.
2788455 - Bone marrow histopathology of patients with severe aplastic anaemia before treatment an...
2808485 - Serum osteocalcin levels in breast cancer patients.
644295 - Serum protein analysis and bone marrow cytology in patients with an extreme elevation o...
19571495 - Is antiplatelet therapy for the prevention of ischemic stroke associated with the progn...
21879275 - Screening for lynch syndrome in colorectal cancer: are we doing enough?
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-04-23
Journal Detail:
Title:  Clinical rheumatology     Volume:  28     ISSN:  1434-9949     ISO Abbreviation:  Clin. Rheumatol.     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-17     Completed Date:  2009-10-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8211469     Medline TA:  Clin Rheumatol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  947-53     Citation Subset:  IM    
Centre for Rheumatology, Department of Medicine, Windeyer Institute, University College London, Room 331, 3rd floor, 46 Cleveland Street, London W1T 4JF, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
African Continental Ancestry Group
Asian Continental Ancestry Group
European Continental Ancestry Group
Follow-Up Studies
Glucocorticoids / adverse effects
Lung Diseases / complications*,  ethnology
Middle Aged
Myositis / complications*,  ethnology
Osteoporosis / chemically induced,  complications*
Prednisolone / adverse effects
Retrospective Studies
Severity of Illness Index
Young Adult
Reg. No./Substance:
0/Glucocorticoids; 50-24-8/Prednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.
Next Document:  Changes in the bacterial populations of the highly alkaline saline soil of the former lake Texcoco (...